BCAR SEC filings, in plain English
Everything D. Boral ARC Acquisition I Corp. has filed with the SEC that we hold — 40 filings, newest first, 38 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: Form 10-Q quarterly report for the period ended June 30, 2026. Subsequent events disclose that on July 29, 2026, shareholders approved the Business Combination with Exascale Labs Inc. and elected to redeem an aggregate of 26,865,211 Class A ordinary shares, representing 95.95% of the outstanding public shares. Why it matters: This massive redemption drains the trust account from $289,883,138 to approximately $12 million, which management states will still satisfy the minimum cash closing condition. The payout leaves roughly 1.135 million shares unredeemed, drastically altering the post-deal capital structure while confirming the transaction will proceed without supplemental financing ahead of the stated January 31, 2027 liquidation deadline.
What changed vs 2026-05-15trust $287.3M → $289.9M +1%trust account, mandate language, combination deadline +22 moved · 3 with no prior record of ours
- Trust account
- $287.3M$289.9M
- Mandate language
- the Company intends to focus on industries that complement o…the Company intends to focus on industries that complement o…
- Combination deadline
- not previously extracted2027-01-31
- Going-concern doubt
- stated · unchanged
- Redeemable shares
- 28.0M · unchanged
SpacBrain reads this as $2,563,451 was added to the trust between the two filings.
The clause “$ ( 1,204,774 ) Interest income on cash held in trust account $ 51,065,109 Cash held in Trust Account $ 289,883,138 The key measures of segment profit or loss reviewed by the CODM are formation and operating costs, interest income on cash”…
The clause …“capital will ultimately be available. In addition, the Company initially has until January 31, 2027 to consummate the initial Business Combination (assume no extensions). If the Company does not complete a Business Combination”…
The clause “14-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation, should a business combination not occur, and potential subsequent dissolution,”…
The clause …“there were 1,200,000 Class A ordinary shares issued or outstanding, excluding 28,000,000 Class A ordinary shares subject to possible redemption. Class B Ordinary shares — The Company is authorized to issue 50,000,000 ordinary shares”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: A Joint Filing Agreement (Exhibit A) attached to a Schedule 13G/A beneficial ownership report, formally executed by Harraden Circle Investments, LLC and Frederick V. Fortmiller, Jr. under the signature block dated August 14, 2026. The attached text discloses no adjustments to share quantities, acquisition percentages, or transactional terms; it solely establishes a procedural arrangement permitting joint SEC submission pursuant to Rule 13d-1(k). Why it matters: Because the attachment contains only boilerplate joint-filing language, it does not influence the BCAR redemption mechanics, trust valuation, extension timeline, or sponsor conduct parameters. Investors tracking institutional positioning should note that the named entities remain subject to continuous Section 13(d) disclosure obligations, but the filing introduces no actionable developments regarding deal progression or shareholder liquidity events.
What changed: A Schedule 13G/A amendment and routine compliance exhibit containing duplicate Powers of Attorney delegating SEC filing authority to Goldman Sachs personnel. The filing supersedes July 16, 2025 delegation instruments by extending the Power of Attorney for seventeen named attorneys-in-fact. The authority remains effective until July 8, 2027 (per The Goldman Sachs Group, Inc., executed July 8, 2026 by Scott Kilpatrick) or July 2, 2027 (per Goldman Sachs & Co. LLC, executed July 2, 2026 by Carey Ziegler). If any named employee leaves their role before those dates, their specific authorization terminates automatically while the remainder stays active. Why it matters: This document bears no weight on BCAR’s redemption calendar, trust value per share ($10.35), deal progress (DEAL_APPROVED), sponsorship conduct, or the 2027-02-01 deadline. It contains zero claims regarding target customers, revenue, market size, strategy, technology, partnerships, litigation, or operational milestones. The filing is purely an administrative update dictating which bank officers may sign future 13G/D/G disclosures for portfolio positions. Investors tracking redemption mechanics, extension triggers, or sponsor accountability should note it alters nothing; it carries no binding effect on merger terms, shareholder redemption rights, or SPAC corporate actions.
What changed: A Form 8-K filed as a Rule 425 written communication formally recording the shareholder voting results from BCAR’s extraordinary general meeting held July 29, 2026, alongside a joint press release (Exhibit 99.1) issued the same day. Per the official voting tabulation, shareholders approved the Business Combination Agreement dated January 11, 2026 with Exascale Labs Inc., the domestication merger transferring BCAR from the British Virgin Islands to Delaware, and related organic governance changes. Redemption elections crystallized at 26,865,211 Class A ordinary shares surrendered, which the filing quantifies as 95.95% of outstanding public shares. According to the joint press release, approximately $12 million remains in the trust account following those redemptions. The filing states this remainder satisfies the minimum cash closing condition under the merger agreement and that neither party currently anticipates pursuing additional financing before closing. Upon closing, PubCo will operate as Exascale Labs Holdings Inc., with securities expected to trade on Nasdaq under symbols XLAB and XLABW. Why it matters: The 95.95% redemption rate strips most trust capital, anchoring post-close liquidity to the disclosed $12 million and removing reliance on PIPE or bridge financing. Governance shifts established in the newly adopted charter impose a two-tier voting structure where each PubCo Class B Super Common Stock carries twenty votes per share versus one vote per PubCo Class A Ordinary Common Stock. Amending core charter provisions will require a 66⅔% affirmative vote across classes, and director removal will be restricted to cause supported by the same supermajority threshold. Five directors were elected with staggered expiration dates: Hoansoo Lee until 2029, Wenying Jia and David Card until 2028, and Shachar Kariv and Jaeyoung Shin until 2027. Regarding business operations, Exascale describes itself in the press release as providing an asset-light, software-defined GPU compute platform that offers reserved and on-demand GPU capacity sourced from third-party data centers globally, complemented by in-house developments in modular data center hardware, high-density cooling, HVDC power, and energy storage. The company positions its architecture as purpose-built for large-scale AI workloads, specifically citing LLM training, fine-tuning, and high-concurrency inference.
What changed: Form 8-K Current Report announcing the results of an Extraordinary General Meeting of shareholders held on July 29, 2026, which approved the business combination with Exascale Labs Inc., accompanied by Exhibit 99.1, a joint press release detailing the vote outcomes and trust status. This filing reports that at a shareholder vote on July 29, 2026, the Agreement and Plan of Merger dated January 11, 2026 was adopted, alongside proposals to domesticate the company from the British Virgin Islands to Delaware, implement a new charter and bylaws, approve an equity incentive plan, and satisfy Nasdaq Listing Rule 5635. Mechanically, shareholders redeemed 26,865,211 Class A ordinary shares, representing 95.95% of the outstanding public shares. Per the attached joint press release, approximately $12 million remains in the trust account following these redemptions, which satisfies the minimum cash closing condition; the parties state they do not currently anticipate pursuing any additional financing prior to closing. Deal progress advances to an imminent closing phase, with the surviving entity re-domiciling as Exascale Labs Holdings Inc. and listing under ticker symbols XLAB and XLABW. Regarding substance, the press release attributes to Exascale a self-description as a next-generation AI infrastructure provider operating an asset-light, software-defined GPU compute platform. The company outlines its core business as GPU-as-a-Service, providing reserved and on-demand access to high-performance GPU compute capacity sourced from third-party data centers globally, plus GPU cluster management and optimization services. Exascale further claims to have developed modular data center, high-density cooling, HVDC power, and energy storage solutions intended to address deployment bottlenecks in AI infrastructure, asserting its platform is purpose-built for large-scale AI workloads including LLM training, fine-tuning, and high-concurrency inference. Governance shifts include a new staggered board through the 2029 annual meeting and the creation of a Class B Super Common Stock class granting twenty votes per share compared to one vote per share for Class A Ordinary Common Stock. Why it matters: The 95.95% redemption severely depletes SPAC liquidity, yet confirming that approximately $12 million satisfies the minimum cash requirement prevents deal collapse from funding shortages and eliminates the need for a potentially dilutive PIPE at closing. The structural shift to a dual-class system permanently concentrates voting control via twenty-to-one super-voting shares, significantly altering post-combination minority shareholder leverage. Clearing all internal shareholder votes removes the primary execution hurdle, making the February 1, 2027 deadline largely procedural unless external conditions trigger termination. Investors tracking trust value will note the stark reduction from prior levels, while those monitoring sponsor conduct will observe reliance solely on retained trust proceeds rather than fresh capital raises.
What changed: A Form 425 communication filed by D. Boral ARC Acquisition I Corp. pursuant to Rule 425 of the Securities Act and Rule 14a-12 of the Exchange Act, containing a press release issued by target company Exascale Labs Inc. This filing does not amend the merger agreement, modify shareholder redemption rights, adjust the trust value ($10.35 per share), or alter the February 1, 2027 liquidation deadline. It instead disseminates a July 21, 2026 press release attributed to Exascale Labs Inc. and quoting Hoansoo Lee, Chief Executive Officer of Exascale, who claimed the company is advancing an 'estimated $300 million customer opportunity pipeline' through recent commercial developments. The filing reports three specific arrangements: (1) a non-binding MOU with RUTILEA for the potential development and commercialization of up to 20MW of data center capacity, noting that while parties expect to negotiate a definitive agreement, 'no assurance can be given'; (2) a recently announced $71.4 million three-year compute services agreement with Dimension AI securing dedicated GPU compute capacity; and (3) a $53 million AI Nova non-binding MOU contemplating initial orders for GPU servers and related technical services, also subject to definitive agreement negotiations without assurance of execution. Additionally, the filing notes Exascale partnered with global IT leader Compal Electronics to showcase modular data center, HVDC, and solid-state transformer offerings at COMPUTEX Taipei 2026. Management characterizes Exascale as operating an asset-light, software-defined GPU compute platform purpose-built for LLM training, fine-tuning, and high-concurrency inference. All pipeline metrics and revenue projections are presented as forward-looking expectations contingent on market demand, GPU supply chains, and binding contract execution. Why it matters: This Rule 425 submission functions exclusively as a commercial progress update and investor relations communication, leaving the SPAC redemption calendar, trust account composition, and extension provisions untouched. For holders tracking deal mechanics, it confirms the transaction remains on track toward the approved business combination while providing zero contractual leverage over redemption timing or trust distributions. From a target viability perspective, the filing highlights management’s strategy to monetize both GPU-as-a-Service and physical infrastructure solutions, but the explicit non-binding status of the $53 million and $300 million pipeline figures significantly tempers near-term cash flow predictability. Only the $71.4 million Dimension AI commitment constitutes a firm financial obligation. The extensive forward-looking disclaimers and conditionality language reinforce that actual revenue recognition depends on successfully negotiating definitive agreements, overcoming hardware procurement bottlenecks, and satisfying merger closing conditions. Investors should weigh these announcements as strategic positioning indicators with no direct mathematical or procedural impact on their redemption calculations or sponsor governance oversight.
What changed: A press release announcing a commercial customer contract, filed as an SEC Form 425 submission because it constitutes prospectus-related communication tied to the pending business combination between D. Boral ARC Acquisition I Corp. and Exascale Labs Inc. Nothing altered regarding the redemption calendar, trust per share balance, extension authorization, or sponsor behavior. The deal remains post-shareholder approval, with the definitive Proxy Statement and registration statement already distributed to BCAR investors as the parties move toward final closing. Why it matters: This filing delivers commercial substantiation rather than mechanical adjustments. Per the filing, Exascale entered a three-year Compute Service Agreement to procure approximately US$71.4 million of dedicated GPU compute capacity from Dimension AI Pte. Ltd., a Singapore-based enterprise technology distributor. Hoansoo Lee, CEO of Exascale, stated that securing long-term access to high-performance GPU capacity represents an important milestone for scaling the AI infrastructure platform and improving service reliability for growing customer needs. Lionel Peh, Director of Dimension AI, remarked that the partnership demonstrates strong demand for dedicated, high-performance compute capacity. The agreement funds expansion of Exascale’s GPU-as-a-Service and token factory platform, which operates an asset-light, software-defined model sourcing reserved and on-demand capacity from global third-party data centers. The filing further details Exascale’s proprietary work on modular data center, high-density cooling, HVDC power, and energy storage solutions designed to resolve AI infrastructure deployment bottlenecks, with the platform optimized for LLM training, fine-tuning, and high-concurrency inference. These confirmed procurement commitments and hardware/software developments validate the merger’s revenue and scalability assumptions while leaving shareholder exit rights and trust distribution procedures entirely unaffected.
What changed: A Form 8-K current report containing Item 8.01 disclosures and Exhibit 99.1, a joint press release that formally schedules an Extraordinary General Meeting of D. Boral ARC Acquisition I Corp. (BCAR) shareholders to vote on a previously executed Agreement and Plan of Merger with Exascale Labs Inc. The filing sets an Extraordinary General Meeting for Wednesday, July 29, 2026 at 10:00 AM Eastern Time, establishing Monday, July 6, 2026 as the record date for shareholder attendance and voting eligibility. The definitive Proxy Statement has been mailed to BCAR shareholders of record. The companies state the Business Combination is expected to close shortly following the shareholder meeting, contingent upon shareholder approval and the satisfaction or waiver of specified closing conditions. While this 8-K does not restate redemption mechanics or trust account balances, it directs investors to the filed Registration Statement on Form S-4 (File No. 333-297214) for complete details on voting procedures, redemption rights, and trust distributions. The filing also confirms registered Class A ordinary shares carry a par value of $0.0001 per share and that whole warrants are exercisable at an exercise price of $11.50 per share. Why it matters: Shareholders face a fixed decision window requiring proxy authorization or redemption execution prior to the July 6, 2026 record date, after which corporate action accelerates toward the anticipated post-meeting closing. According to the joint press release, upon closing the combined enterprise will operate as Exascale Labs Holdings Inc. and list on Nasdaq under ticker “XLAB.” The press release describes Exascale as a next-generation AI infrastructure provider offering GPU-as-a-Service through reserved and on-demand access to high-performance GPU compute capacity sourced from third-party global data centers, supplemented by GPU cluster management and optimization services. The company states it has developed modular data center, high-density cooling, HVDC power, and energy storage solutions intended to resolve AI infrastructure deployment bottlenecks, with a platform engineered for large-scale AI workloads including LLM training, fine-tuning, and high-concurrency inference. Forward-looking statements attributable to BCAR, Exascale, and PubCo caution that actual outcomes may differ materially due to supply constraints for GPUs and related components, shifts in customer demand, competitive pressures, technological risks, operational performance variables, regulatory changes, and macroeconomic factors.
What changed: A Form 8-K filing pursuant to Rule 425 containing a joint press release that schedules an Extraordinary General Meeting of D. Boral ARC Acquisition I Corp. (BCAR) shareholders to approve a previously announced business combination agreement dated January 11, 2026. The filing establishes the shareholder meeting date for Wednesday, July 29, 2026 at 10:00 AM Eastern Time, with a record date of Monday, July 6, 2026. It confirms the definitive Proxy Statement has been mailed to BCAR shareholders and states the business combination is expected to close shortly following shareholder approval, subject to the satisfaction or waiver of certain closing conditions. Why it matters: This filing fixes the proximate deadline for BCAR investors to examine proxy disclosures, exercise redemption rights, and cast votes ahead of the July 29 meeting. Attached is a July 7, 2026 press release attributing to Exascale Labs Inc. a business model defined as an 'asset-light, software-defined GPU compute platform' delivering reserved and on-demand GPU access via third-party global data centers, alongside GPU cluster management and optimization services. The same release attributes to Exascale the creation of modular data centers, high-density cooling, HVDC power, and energy storage solutions designed to resolve AI infrastructure deployment bottlenecks for LLM training, fine-tuning, and high-concurrency inference workloads. BCAR and Exascale jointly announce the combined company will operate as Exascale Labs Holdings Inc. and list on Nasdaq under the ticker 'XLAB'. All operational descriptions, technology roadmaps, and market positioning claims are sourced exclusively to the joint Exascale and BCAR press release. The filing also lists a whole warrant exercise price of $11.50 per share for BCARW.
What changed: Definitive 424(b)(3) proxy statement/prospectus (Reg. No. 333-297214) for D. Boral ARC Acquisition I Corp.'s combination with Exascale Labs Inc. under an Agreement and Plan of Merger dated January 11, 2026, registering up to 60,456,000 Class A shares, 30,744,000 Class B super-voting shares and 14,100,000 warrants. BCAR redomiciles from the BVI to Delaware by merging into D. Boral ARC Merger Corporation, which is renamed Exascale Labs Holdings Inc., then Merger Sub merges into Exascale, an asset-light GPU-as-a-Service and AI-infrastructure provider whose modular data center, liquid cooling, HVDC and energy-storage products have generated no revenue to date. Merger consideration is a fixed 50,000,000 PubCo shares (19,256,000 Class A and 30,744,000 Class B). Class B carries 20 votes per share, so former Exascale holders control 91.1% of the vote with no redemptions, 93.0% at 50% redemption and 95.0% at maximum redemption, while non-affiliated public holders fall from 28,000,000 shares (30.7% economic, 4.2% voting) to zero at maximum redemption. Insiders receive 13,200,000 shares (12,000,000 sponsor Class B, 200,000 private-unit shares, 1,000,000 representative shares held by BCAR's Chairman/CEO). Nasdaq listing under XLAB/XLABW is applied for and is a closing condition; 100,000 private and 14,000,000 public warrants are excluded from the tables. Why it matters: The 20-vote Class B structure hands the target absolute voting control (91%-95%) on day one regardless of redemptions, so public holders are buying a non-controlling economic stub in an AI-infrastructure company whose hardware lines have zero revenue. A fixed 50 million share price means redemptions transfer ownership to sellers rather than reducing what they receive.
minimum cash condition, outside datenothing moved · 2 with no prior record of ours
- Minimum cash condition
- $5.0M · unchanged
- Outside date
- 2026-09-01 · unchanged
The clause …“and other Exascale founders and have 20 votes per share, and (iv) included a minimum cash condition of $5.0 million. 122 Table of contents On September 22, 2025, Mr. Darwin and Mr. Lee held a telephonic meeting during which they”…
The clause …“A- 70 Table of contents (d) By either the Company or Parent: (i) On or after September 1, 2026 (the Outside Date ), if the Merger shall not have been consummated prior to the Outside Date; provided , however , that the right to”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Definitive Proxy Statement/Prospectus (DEFM14A) for an Extraordinary General Meeting scheduled for July 29, 2026, designed to solicit shareholder votes on the proposed business combination, corporate domestication, and associated governance amendments between D. Boral ARC Acquisition I Corp. (BCAR) and Exascale Labs Inc. The filing establishes a definitive voting timeline ahead of the February 1, 2027 business combination deadline (extendable to May 1, 2027 if the Sponsor exercises its three-month extension option). Per the BCAR Board, the trust account held approximately $290,025,825.19 as of July 6, 2026, implying a per-share redemption price of approximately $10.36. The BCAR Board states that Exascale securityholders will collectively receive 50,000,000 PubCo Common Stock valued at $10.00 per share for a $500,000,000 consideration. The filing confirms that no Minimum Cash Financing of at least $5,000,000 has been secured as of the document date. Regarding sponsor conduct, the BCAR Board discloses that MFH 1, LLC invested an aggregate of $2,025,000 across 12,000,000 Founder Shares and 200,000 Private Units, and outlines ongoing monthly administrative service obligations of $20,000 alongside potential working capital loans up to $2,500,000. Deal progress reflects unanimous board approvals for all eight proposals, with sponsorship support agreements locked in, lock-up commitments executed for Exascale holders, and proxy solicitation costs fixed at $12,500 plus disbursements via Advantage Proxy. Why it matters: Acquiring shareholders must decide whether to hold, vote, or exercise redemption rights before the February 1, 2027 cutoff, directly impacting their exposure to a transaction that the BCAR Board calculates would yield an implied post-combination value of $4.80 per share—a 53.69% decrease from the $10.36 trust baseline. This structural dilution creates explicitly acknowledged conflicts of interest, as the BCAR Board warns sponsors may be incentivized to close rather than liquidate despite potential value erosion for public investors. Exascale’s audited financials reveal recurring net losses, an accumulated deficit of $21,134,012 as of March 31, 2026, and a going concern qualification, while Exascale management projects rapid top-line expansion reaching $20.0 million for 2026, $40.0 million for 2027, and $80.0 million for 2028. Exascale’s strategic positioning relies on an asset-light, software-defined GPU compute platform and GaaS model targeting a market a September 2025 Gartner report projected would reach nearly $1.5 trillion in 2025 and exceed $2.0 trillion in 2026, though Exascale notes its complementary infrastructure solutions have yet to generate commercial revenue and the company historically served 55 distinct customers with single-client revenue concentrations exceeding 14.0%. No pending or threatened litigation is reported, and key executive transitions place Hoansoo Lee and Wenying Jia in dual CEO/Chair roles under the new PubCo governance structure, with five appointed directors including independent academicians and industry investors.
minimum cash condition, outside datenothing moved · 2 with no prior record of ours
- Minimum cash condition
- $5.0M · unchanged
- Outside date
- 2026-09-01 · unchanged
The clause …“and other Exascale founders and have 20 votes per share, and (iv) included a minimum cash condition of $5.0 million. 122 Table of contents On September 22, 2025, Mr. Darwin and Mr. Lee held a telephonic meeting during which they”…
The clause …“A- 70 Table of contents (d) By either the Company or Parent: (i) On or after September 1, 2026 (the Outside Date ), if the Merger shall not have been consummated prior to the Outside Date; provided , however , that the right to”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: S-4 registration statement (proxy statement/prospectus) filed by D. Boral ARC Acquisition I Corp. (BCAR) to register securities and solicit shareholder approval for the proposed business combination with Exascale Labs Inc., including a domestication merger and acquisition merger. This is the initial filing of the S-4, which sets forth the terms of the business combination agreement, the merger consideration, pro forma ownership, redemption rights, financial statements of both BCAR and Exascale, risk factors, and the proxy solicitation for the extraordinary general meeting scheduled for 2026. No prior S-4 had been filed; this is the first comprehensive disclosure of the transaction. Why it matters: The filing contains the definitive terms of the de-SPAC transaction, including the $500 million enterprise value, the 50 million share merger consideration, the dual-class voting structure (Class A 1 vote, Class B 20 votes), the minimum cash condition of $5 million, and the redemption mechanics. It provides the target company's financials (Exascale had $7.0M revenue in FY2025, net loss of $7.7M) and key risk factors including going concern qualification. The filing also sets the redemption deadline (two business days before the meeting) and indicates the trust account value per share (approximately $10.26 as of March 31, 2026). The deadline for business combination is February 1, 2027 (extendable to May 1, 2027).
minimum cash condition, outside datenothing moved · 2 with no prior record of ours
- Minimum cash condition
- $5.0M · unchanged
- Outside date
- 2026-09-01 · unchanged
The clause …“and other Exascale founders and have 20 votes per share, and (iv) included a minimum cash condition of $5.0 million. 122 Table of contents On September 22, 2025, Mr. Darwin and Mr. Lee held a telephonic meeting during which they”…
The clause …“A- 70 Table of contents (d) By either the Company or Parent: (i) On or after September 1, 2026 (the “ Outside Date ”), if the Merger shall not have been consummated prior to the Outside Date; provided , however , that the right to”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: S-4/A (Amendment No. 1 to Registration Statement on Form S-4) containing a Proxy Statement and Prospectus for a proposed business combination. Per the Proxy Statement, this amendment incorporates unaudited financial statements through March 31, 2026; revises organizational document proposals to codify dual-class voting rights granting twenty votes per PubCo Class B Super Common Stock share; discloses that Exascale’s management acknowledges substantial doubt regarding its ability to continue as a going concern due to recurring net losses and negative cash flows; confirms neither BCAR nor Exascale has secured the $5,000,000 Minimum Cash Financing condition precedent as of the filing date; and clarifies governance rules permitting the Sponsor to privately acquire up to 15% of Public Shares to reduce redemptions. Why it matters: As outlined in the Risk Factors and proxy materials, these disclosures are critical because the merger remains contingent on securing alternative financing, obtaining shareholder approval, and navigating sponsor economic conflicts (e.g., Founder Shares acquired for $25,000 converting to approximately 12.2 million PubCo shares post-deal). The updated financials and going concern warning directly impact the valuation trajectory relative to the February 1, 2027 liquidation deadline, while the dual-class structure and private share purchase mechanisms materially alter redemption economics and concentrate post-merger voting control with Exascale founders.
minimum cash condition, outside datenothing moved · 2 with no prior record of ours
- Minimum cash condition
- $5.0M · unchanged
- Outside date
- 2026-09-01 · unchanged
The clause …“and other Exascale founders and have 20 votes per share, and (iv) included a minimum cash condition of $5.0 million. 122 Table of contents On September 22, 2025, Mr. Darwin and Mr. Lee held a telephonic meeting during which they”…
The clause …“not be met, and such breach has not been cured within the earlier of (A) September 1, 2026 (the “Outside Date”) and (B) thirty (30) days following the receipt by Exascale of a notice describing such breach; ● Exascale, if BCAR,”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Form S-4/A merger proxy statement/prospectus. Amendment No. 1 to the registration statement adding updated unaudited pro forma financials, refined U.S. federal income tax disclosures, clarified shareholder voting quorum and redemption delivery mechanics, updated director nominee biographies, and expanded conflict-of-interest, risk factor, and Minimum Cash Financing disclosures relative to the base S-4. Why it matters: The filing discloses the precise timeline and conditions governing shareholder capital allocation: Public Shareholders must deliver certificates or utilize the DWAC system at least two business days prior to the Extraordinary General Meeting to exercise redemption rights. The BCAR Board and management confirm a mandatory $5,000,000 Minimum Cash Financing condition precedent, warn that the SPAC will liquidate on February 1, 2027 (extendable to May 1, 2027 via Sponsor election), and detail the post-combination dual-class structure where 30,744,000 PubCo Class B Super Common Stock (held by Exascale founders and affiliated trusts/entities) will carry 20 votes per share, resulting in 89.2% to 95.0% voting control depending on redemption levels. It also attributes heavy sponsor economic exposure to the deal's success, noting the $2,025,000 combined cost for Founder Shares and Private Units becomes worthless upon failure, while the trust balances outlays roughly $10.35 per share.
minimum cash condition, outside datenothing moved · 2 with no prior record of ours
- Minimum cash condition
- $5.0M · unchanged
- Outside date
- 2026-09-01 · unchanged
The clause …“and other Exascale founders and have 20 votes per share, and (iv) included a minimum cash condition of $5.0 million. 122 Table of contents On September 22, 2025, Mr. Darwin and Mr. Lee held a telephonic meeting during which they”…
The clause …“not be met, and such breach has not been cured within the earlier of (A) September 1, 2026 (the “Outside Date”) and (B) thirty (30) days following the receipt by Exascale of a notice describing such breach; ● Exascale, if BCAR,”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Schedule 13G beneficial ownership report. The filing excerpt identifies Merus Global Investments, LLC as the reporting holder under SEC accession number 0001104659-26-072483, but discloses no change in position, purchase or sale activity, percentages, or share quantities. Why it matters: Routine Schedule 13G filings conventionally indicate that the named entity has crossed the 5% beneficial ownership threshold, which can signal institutional accumulation or positioning ahead of corporate events. Because the provided text supplies no numerical stakes, transaction dates, or stated investment purpose, it offers no actionable insight on BCAR’s redemption mechanics, trust value preservation, deadline pressures, deal advancement, or sponsor conduct. The excerpt contains zero claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel, making it immaterial to near-term SPAC operational tracking.
What changed: Form 8-K Current Report furnishing Exhibit 99.1, a May 27, 2026 press release announcing Exascale Labs’ participation in the Guosheng Securities SST Industry Forum. The filing leaves the redemption deadline of February 1, 2027, and the trust account mechanics unchanged. It confirms the deal progression initiated by the Agreement and Plan of Merger dated January 11, 2026, notes the Registration Statement on Form S-4 was filed on May 14, 2026, and reiterates that Exascale expects the transaction to close in the second half of 2026. The combined entity will operate as Exascale Labs Holdings Inc., list on Nasdaq under ticker XLAB, and maintains Class A ordinary shares with a $0.0001 par value and warrants exercisable at $11.50 per share. Why it matters: Beyond schedule confirmation, the press release delivers strategic claims attributed to Dr. Hoansoo Lee, Chief Executive Officer of Exascale. Dr. Lee asserts that AI data centers are entering a phase where power delivery, rather than just compute or networking, has become the primary bottleneck, and that solid-state transformer (SST) and high-voltage direct current (HVDC) architectures will enable higher-density GPU deployments with greater efficiency and a smaller electrical footprint. He draws a parallel to how co-packaged optics redefined optical communications. Exascale outlines its platform’s offerings as GPU-as-a-Service, GPU cluster management, modular data center solutions, high-density cooling, HVDC/SST power systems, and energy storage tailored for large-scale AI workloads including LLM training and fine-tuning. The company plans to showcase its Vera Rubin Data Center stack and discuss North American demand for AI compute infrastructure. These narratives do not alter redemption mechanics or trust disbursement, but they frame the commercial thesis and technological differentiation presented to institutional investors ahead of the proxy voting period, supporting the investment rationale for the business combination.
What changed: A Form 8-K filed pursuant to Rule 425 transmitting a written communication consisting of a May 27, 2026 press release that functions as a pre-merger investor/presentation update announcing executive participation at an industry conference. The filing introduces no adjustments to the redemption calendar, trust account distribution rules, extension procedures, or sponsor conduct. Deal status aligns with the January 11, 2026 Agreement and Plan of Merger, with Exascale maintaining its stated expectation that the business combination will close in the second half of 2026. Upon consummation, the surviving entity will operate as Exascale Labs Holdings Inc. and list on Nasdaq under ticker “XLAB.” Registered securities parameters remain fixed at a Class A ordinary share par value of $0.0001 and whole warrant exercise price of $11.50 per share. Why it matters: While this transmission leaves shareholder mechanics untouched, it crystallizes Exascale’s public strategic thesis ahead of the proxy mailing. Per the press release, Dr. Hoansoo Lee, Chief Executive Officer of Exascale, stated that “AI is forcing every layer of data center infrastructure to be redesigned,” and identified power delivery as the sector’s next binding constraint. Dr. Lee asserted that solid-state transformer and high-voltage direct current architectures “can help data centers support higher-density AI workloads with greater efficiency, faster deployment, and a more compact electrical footprint.” Exascale characterized its proprietary technology platform—the “Vera Rubin Data Center stack”—as engineered to resolve customer deployment bottlenecks spanning compute availability, power density, liquid cooling, modular data center design, and operational optimization. The company further outlined its commercial offerings as GPU-as-a-Service, GPU cluster management, modular data center solutions, high-density cooling, HVDC and solid-state transformer power systems, and energy storage solutions targeted at LLM training, fine-tuning, and high-concurrency inference. These assertions are explicitly labeled forward-looking, subject to documented risks including “supply constraints for GPUs and related infrastructure components,” “competitive pressures,” and “technological risks,” and they rely on the company’s internal positioning rather than independently audited historical financials. Investors should await the forthcoming proxy statement/prospectus for verified revenue streams, customer contracts, and balance sheet composition before treating these technological and capacity claims as established fundamentals.
What changed: This document is a Form 8-K current report filed by D. Boral ARC Acquisition I Corp. under Item 8.01 and Item 9.01 to furnish a press release (Exhibit 99.1) issued by Exascale Labs Inc. on May 19, 2026, announcing a strategic partnership with Compal Electronics, Inc. for a joint exhibition at COMPUTEX Taipei 2026, submitted as written communications under Securities Act Rule 425 in connection with a pending business combination. No adjustments were made to the redemption deadline, trust account balance, merger agreement terms, proxy voting schedule, or sponsor conduct; the underlying January 11, 2026 Agreement and Plan of Merger remains unchanged. On the substantive front, Exascale announced a partnership with Compal Electronics (TWSE: 2324) to showcase an integrated AI data center stack at Computex Taipei 2026 (June 2–5, 2026) in booth M0804. Dr. Hoansoo Lee, CEO of Exascale Labs, stated that the combined solution—pairing Compal’s AI server platforms (OG231-2-L1, OG430-2-L1, SGX30-2) and Direct Liquid Cooling with Exascale’s Modular Data Center and HVDC/SST power architecture—enables joint customers to move from purchase order to live AI capacity in months rather than years. Alan Chang, Vice President of ISBG at Compal, attributed the collaboration to resolving heightened rack-level power and thermal demands, asserting Exascale’s facility-grade infrastructure complements Compal’s chip- and rack-level engineering. The release also reiterates that the BCAR-Exascale combination, agreed upon in early 2026, targets closure in the second half of 2026, with the post-transaction entity trading on Nasdaq as XLAB. Why it matters: Although the filing leaves the $10.35 trust share value, the February 1, 2027 redemption window, and the deal structure intact, it delivers commercial validation ahead of the anticipated H2 2026 closing. Partnering with a publicly traded, globally recognized hardware manufacturer provides third-party corroboration of Exascale’s full-stack deployment thesis, which typically stabilizes shareholder sentiment during the proxy solicitation phase. For investors weighing redemption against continuation, the announcement signals unimpeded operational momentum and channel development without altering economic terms or triggering de-spacification delays, suggesting management is advancing commercial readiness rather than renegotiating terms.
What changed: This filing is a Form 8-K current report submitted pursuant to Rule 425 under the Securities Act, functioning as a written communication vehicle to incorporate Exhibit 99.1, a May 19, 2026 press release issued by Exascale Labs Inc. Regarding deal mechanics, the document confirms execution continuity on the Agreement and Plan of Merger originally executed on January 11, 2026, with Exascale and BCAR management projecting closing in the second half of 2026 so the combined entity can list on Nasdaq under ticker XLAB. The filing does not amend, extend, or alter the stated $10.35 per share trust account value, the February 1, 2027 redemption deadline, or any sponsor conduct provisions. Why it matters: Beyond the mechanics, the incorporated press release details commercial developments without financial disclosures; Exascale Labs CEO Dr. Hoansoo Lee claims coupling Compal’s hardware with Exascale’s infrastructure will allow joint customers to move from purchase order to live AI capacity in months rather than years, while Compal Vice President Alan Chang attributes complementary thermal and power challenges to their respective product lines. The text specifies Compal will display AI server platforms including OG231-2-L1, OG430-2-L1, and SGX30-2 systems alongside Direct Liquid Cooling technology, paired with Exascale’s Modular Data Center and 800 V DC solid-state transformer architecture. The showcase is scheduled for Computex Taipei 2026 (June 2-5, 2026 at booth M0804). For holders weighing redemption versus remaining in the trust vehicle, this filing provides verified operational narrative and partnership validation ahead of the February 1, 2027 termination window, though no pricing, revenue, or customer contract figures are supplied.
What changed: D. Boral ARC Acquisition I Corp.'s Form 10-Q for the quarter ended March 31, 2026, filed May 15, 2026 — a routine quarterly compliance filing containing unaudited condensed financial statements, MD&A, controls disclosures and certifications. Trust cash is reported at $287,319,687 at March 31, 2026 versus $284,776,628 at December 31, 2025, and Class A ordinary shares subject to possible redemption are carried at $10.26 per share at March 31, 2026 versus $10.17 at December 31, 2025. Operating cash fell from $420,340 to $243,576 and working capital was $54,122. The quarter produced $2,543,059 of trust interest income, $531,741 of operating costs, and net income of $2,011,318. The filing restates the January 11, 2026 Merger Agreement with Exascale Labs Inc. — $500,000,000 consideration payable as 50,000,000 new PubCo shares valued at $10.00 per share, effected through a BVI-to-Delaware reincorporation merger followed by an acquisition merger — but discloses no shareholder meeting, tender offer, redemption deadline, or extension election. It also reports no subsequent events, no litigation, and no change in internal control over financial reporting. Why it matters: This is the trust-value and deal-progress checkpoint for BCAR holders: the Company confirms the trust holds $287,319,687, or $10.26 per redeemable share, and states the underwriters will not be entitled to any deferred underwriting fee at closing of the business combination, so redemption proceeds are not reduced by that item. It reiterates the Exascale transaction remains the intended business combination and that the combination period is 18 months from the August 1, 2025 IPO close, with one optional three-month sponsor extension. The filing also highlights sponsor conduct and risk: sponsor MFH 1, LLC waived redemption rights, may convert up to $2,500,000 of working capital loans into private units, has not been asked to reserve for its trust indemnification, and its only assets are company securities. With operating cash of $243,576, working capital of $54,122, and substantial doubt about going concern absent a closing, this filing matters for anyone tracking BCAR's timeline, trust value, and deal execution risk.
What changed vs 2025-11-05trust $282.0M → $287.3M +2%going concern APPEAREDtrust account, going-concern doubt, mandate language +23 moved · 2 with no prior record of ours
- Trust account
- $282.0M$287.3M
- Going-concern doubt
- not statedstated
- Mandate language
- the Company intends to focus on industries that complement o…the Company intends to focus on industries that complement o…
- Sponsor loans outstanding
- $214Knot matched in this filing
- Redeemable shares
- 28.0M · unchanged
SpacBrain reads this as $5,356,466 was added to the trust between the two filings.
The clause …“$ ( 531,741 ) Interest income on cash held in trust account $ 2,543,059 Cash held in Trust Account $ 287,319,687 The key measures of segment profit or loss reviewed by the CODM are formation and operating costs, interest income on cash”…
SpacBrain reads this as the substantial-doubt sentence is in this filing and not in the previous one.
The clause …“be available. The liquidity condition and mandatory liquidation raise substantial doubt about the Company s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the”…
The clause …“there were 1,200,000 Class A ordinary shares issued or outstanding, excluding 28,000,000 Class A ordinary shares subject to possible redemption. Class B Ordinary shares The Company is authorized to issue 50,000,000 ordinary shares with”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Schedule 13G/A amendment reporting beneficial ownership of securities. According to the filing text submitted by Meteora Capital, LLC, this document amends a prior Schedule 13G to update beneficial ownership disclosures. The excerpt specifies no adjusted share quantities, ownership percentages, or modifications to redemption deadline mechanics, trust value, extension provisions, deal progress, or sponsor conduct. Beyond identifying Meteora Capital, LLC as the holder and referencing the assignment number [0001905106-26-000063], the text contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: As a 13G/A, it fulfills ongoing SEC disclosure obligations under Section 13(d) following initial reporting or material changes. Without the complete data schedules or narrative statements typically attached to Meteora Capital, LLC’s submission, investors cannot determine whether the holder raised, lowered, or maintained its stake, nor can they assess how the amended ownership might influence voting outcomes, trustee oversight, or the timing of the SPAC’s approved merger or liquidation processes.
What changed: A Schedule 13G/A beneficial ownership report filed by Polar Asset Management Partners Inc. This amended regulatory filing updates reported equity holdings for D. Boral ARC Acquisition I Corp. (BCAR). The provided excerpt does not list amended share totals, ownership percentages, or shifts in sole versus shared voting and investment authority. Mechanically, it does not trigger any redemptions, affect the already approved merger pathway, alter the $10.35 per share trust balance, or modify the 2027-02-01 contractual deadline. Why it matters: As a standard SEC disclosure tracking institutional capital allocation, it confirms ongoing market participation without introducing new operational, financial, or strategic variables. No attributable claims regarding customer bases, revenue streams, market sizing, corporate strategy, technology assets, partnership structures, litigation exposure, or personnel changes are contained within the submission. The document remains a routine compliance exhibit with no immediate impact on shareholder redemption decisions or sponsor governance reviews.
What changed: A Schedule 13G beneficial ownership report. The filing identifies Highbridge Capital Management, LLC as the reporting holder submitting the Schedule 13G. The provided excerpt contains no additional text, so the holder makes no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, personnel, or adjustments to redemption deadlines, trust accounts, deal progression, or sponsor conduct. Why it matters: As a standard equity-ownership compliance filing, it does not alter the $10.35 per share trust value, the Deal_Approved status, or the February 1, 2027 deadline. It introduces no new mechanisms for shareholder redemptions, trust account extensions, or liquidation triggers, and provides no information on sponsor behavior or target-company fundamentals that would affect investor positioning relative to the stated timeline or valuation metrics.
What changed: S-4 Registration Statement under the Securities Act of 1933, filed by D. Boral ARC Merger Corporation (to be renamed Exascale Labs Holdings Inc.), containing a proxy statement/prospectus for BCAR’s extraordinary general meeting to approve a business combination with Exascale Labs Inc., an AI infrastructure provider. Exascale is described as a next-generation AI infrastructure provider operating an asset-light, software-defined GPU compute platform (GaaS) with revenue from GPU cluster management services; it has also developed modular data center, liquid cooling, HVDC power and energy storage solutions that have not yet generated revenue. The merger consideration is 50 million shares of PubCo Common Stock valued at $500 million. The filing includes pro forma ownership tables showing that under a 100% redemption scenario, non-affiliated public shareholders would own 0% of PubCo. The filing discloses that BCAR has identified material weaknesses in internal control over financial reporting. It also reveals that the BCAR Board did not obtain a fairness opinion. The trust value per share is implied at $10.35 per the status line, but the filing does not state the exact trust account balance or per-share redemption price in dollars, leaving those blanks. The minimum cash condition at closing is $5 million, and as of the filing date neither BCAR nor Exascale had secured financing for it. The deadline for the business combination is February 1, 2027 (with a possible three-month extension to May 1, 2027). Why it matters: This filing provides the first detailed public disclosure of Exascale’s business model, financial statements, risk factors, and the transaction structure. It reveals that Exascale has a going concern qualification, incurred net losses of $7.7 million in fiscal year 2025 and $5.3 million in the six months ended December 31, 2025, and had only $1.0 million in cash as of December 31, 2025. The dual-class voting structure (Class B with 20 votes per share vs. Class A with 1 vote) concentrates control with the founders, a significant governance consideration. The absence of a fairness opinion, reliance on valuation benchmarking with large-cap comparables, and the material weaknesses in internal controls are notable risk factors. The filing also warns that the Domestication Merger may be a taxable event for U.S. holders, and that BCAR may be treated as a PFIC.
minimum cash condition, outside datenothing moved · 2 with no prior record of ours
- Minimum cash condition
- not previously extracted$5.0M
- Outside date
- 2026-09-01 · unchanged
SpacBrain reads this as the min-cash condition binds at $5,000,000.
The clause …“and other Exascale founders and have 20 votes per share, and (iv) included a minimum cash condition of $5.0 million. 121 Table of contents On September 22, 2025, Mr. Darwin and Mr. Lee held a telephonic meeting during which they”…
The clause …“A- 70 Table of contents (d) By either the Company or Parent: (i) On or after September 1, 2026 (the “ Outside Date ”), if the Merger shall not have been consummated prior to the Outside Date; provided , however , that the right to”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Routine compliance exhibit (Exhibit A / Joint Filing Agreement) appended to a Schedule 13G/A beneficial ownership report. Nothing altered regarding the redemption deadline, trust per share, extension options, merger execution, or sponsor actions. The text records only that Harraden Circle Investments, LLC; Harraden Circle Investors GP, LP; Harraden Circle Investors GP, LLC; Harraden Circle Investors, LP; Harraden Circle Special Opportunities, LP; Harraden Circle Strategic Investments, LP; Harraden Circle Concentrated, LP; and Frederick V. Fortmiller, Jr. contracted to file one unified Schedule 13G/A on their combined behalf pursuant to Rule 13d-1(k). No modifications to shareholder exit windows, capital preservation targets, or acquisition milestones are present. Why it matters: Executed on May 14, 2026, the agreement shows Mr. Fortmiller asserting Managing Member status and signature power for every listed Harraden Circle vehicle. Because the filing contains zero assertions about client pipelines, sales volumes, addressable markets, operational strategies, proprietary systems, commercial alliances, legal disputes, or leadership changes, its analytical weight rests entirely on corporate governance transparency. Tracking how these eight affiliated funds pool their voting shares reveals whether a single decision-maker controls potential tender blocks, informs base-cases for extension approvals, and sets expectations for how concentrated capital deploys when approaching the expiration date.
What changed: Schedule 13G/A — beneficial ownership report. The filing, submitted by Glazer Capital, LLC and Paul J. Glazer, amends their beneficial ownership disclosure. The provided text lists only the reporting entity names and the filing type; it does not state a numerical change in shares held, percentage owned, or acquisition price. Mechanically, the document makes no reference to the trust/share $10.35 balance, the deadline 2027-02-01, redemption patterns, extension procedures, or sponsor conduct. Why it matters: As a routine compliance exhibit tracking coordinated beneficial ownership, this amendment does not trigger redemption thresholds, alter the approval status, or shift control over shareholder votes beyond standard reporting obligations. The filers make no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Consequently, the document carries no immediate pricing or execution weight for investors monitoring the deal pipeline or trust mechanics.(flagged for human review)
What changed: Routine compliance exhibit — Schedule 13G/A amendment to a beneficial ownership report submitted by Aristeia Capital, L.L.C. Per the filing excerpt, there are no reported alterations to any trust mechanics, redemption deadlines, extension proposals, deal progress, or sponsor conduct. The amendment type indicates a regulatory update to the holder’s disclosure rather than a modification of transaction timelines or shareholder rights. Why it matters: The document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. According to the submission, it functions solely as a statutory ownership disclosure update. For investors tracking the issuer, this filing does not signal sponsor distress, proposed extensions, or shifts in voting control that would accelerate redemptions or alter the approved transaction. It remains administratively routine absent the omitted exhibit body disclosing specific share counts, percentages, or investment intentions.
What changed: Schedule 13G beneficial ownership report appended with two corporate Powers of Attorney granting execution authority for future SEC filings to designated Goldman Sachs personnel. The filing attaches two Powers of Attorney, executed on July 16, 2025, by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC, which appoint seventeen named employees as Attorneys-in-Fact to submit regulatory disclosures under Rule 13f-1 or Regulation 13D-G. According to the attached text, these instruments formally supersede earlier authorizations issued on July 29, 2024, and October 1, 2024, and remain active until July 16, 2026, unless unilaterally revoked. Neither entity discloses amended share counts, acquisition costs, or amendment reasons within the submitted excerpt. Why it matters: For D. Boral ARC Acquisition I Corp., which holds a DEAL_APPROVED status, a $10.35 trust/share reference point, and a 2027-02-01 deadline, this submission operates entirely outside the SPAC’s redemption and merger machinery. The document exclusively manages internal compliance delegation at a participating financial institution. It does not alter the cash-redemption window, change the timing or valuation of trust distributions, provide the sponsor with extension discretion, or signal movement in target due diligence or bridge financing. Public investors face no operational shifts from this administrative proxy renewal.
What changed: Form 8-K furnishing a confidential 'testing-the-waters' investor presentation dated April 28, 2026, detailing a proposed merger between D. Boral ARC Acquisition I Corp. and Exascale Labs Inc., including forward-looking statement disclaimers and proxy solicitation participant lists. The filing discloses updated transaction mechanics featuring a $500M pre-money valuation implying a $632M pro forma enterprise value, alongside illustrative capital tables modeling both 0% and 100% shareholder redemptions against BCAR's stated $280.0M cash in trust. Under the Agreement and Plan of Merger, Exascale securityholders are slated to roll over 100% of their equity. The presentation explicitly notes that BCAR has not yet secured financing for the contractual Minimum Cash Financing obligation of at least $5,000,000. Additionally, the document identifies that outstanding whole warrants are exercisable at $11.50 per share. Why it matters: Management attributes specific operational and financial metrics to Exascale: audited GAAP revenue figures rose from $1,319 (FY2024) to $7,016 (FY2025), with $6,807 recorded in H1 FY2026 compared to $2,614 in the prior-year period. The company reports 22 enterprise customers across 12 countries, a 92% client retention rate, and $300K in annualized average revenue per customer. Management projects a $300M–$500M qualified pipeline spanning 15 active opportunities across North America and APAC, representing approximately 500 MW of prospective deployment capacity. Strategically, Exascale emphasizes an asset-light, software-defined model utilizing modular data centers, HVDC/solid-state transformer power architectures, and high-density liquid cooling. Prior financing milestones cited include a November 2025 $500K bridge SAFE at a $300M cap, a December 2024 $7.501M SAFE at a $150M cap, and a March 2026 $3M SAFE at a $500M cap. The designated Board features CEO Hoansoo Lee, Chairperson Wenying Jia, Lead Director Prof. David Card, and Compensation Committee Chair Prof. Shachar Kariv. For macroeconomic context, Exascale attributes industry forecasts from McKinsey, Bain & Company, Introl, S&P Global, Deloitte, Reuters, Turner & Townsend, and IEA, citing a projected $5.2T global AI-ready data center capital expenditure market by 2030 and listing 2026 hyperscaler spending estimates sourced directly from Microsoft, Alphabet, Amazon, Meta, OpenAI, and SoftBank.
What changed: SEC Form 425 filing submitting a Rule 425 written communication that attaches an investor presentation dated April 28, 2026, prepared jointly by D. Boral ARC Acquisition I Corp. (BCAR) and Exascale Labs Inc. to outline commercial, financial, and operational details surrounding their proposed business combination. The presentation recalibrates the transaction’s capital structure around two redemption extremes applied to BCAR’s $280.0M cash in trust. The minimum scenario assumes 0% redemptions, preserving 91.2 million outstanding shares at a $10.00 assumed share price, while the maximum scenario models 100% redemptions, compressing outstanding shares to 63.2 million and draining all SPAC trust liquidity. The governing Business Combination Agreement obligates PubCo to close with a minimum of $5,000,000 in combined funding sources (trust cash, PIPE, equity lines, or third-party financing), yet BCAR expressly disclosed it had not secured capital to satisfy this floor as of the document date. The capitalization model also assumes zero incremental PIPE proceeds, tying all post-close liquidity directly to trust balances and Exascale rollover equity. Why it matters: Attributed to the investor presentation and Exascale management, audited revenues reached $7,016 thousand for the fiscal year ended June 30, 2025 versus $1,319 thousand for FY2024, with $6,807 thousand recorded in the six months ended December 31, 2025, expanding reported gross margins from 4.2% to 15.8%. Management attributes 22 enterprise customers across 12 countries, a 92% fiscal-year retention cohort, a 95.5% average GPU utilization rate, and an annualized average revenue per customer of $300 thousand. Strategically, management positions the company as an asset-light, software-defined deployment partner competing on engineering velocity rather than capital intensity, supplying GPU-as-a-Service alongside modular data centers, high-density liquid cooling, and Solid State Transformer HVDC power architectures. Market sizing and macro tailwinds are attributed to cited external authorities (McKinsey, Bain, IEA, Bloomberg, S&P Global, Deloitte, Reuters, and hyperscaler disclosures), projecting a $5.2 trillion AI addressable market by 2030, AI workloads consuming 70% of data center capacity, and over $690 billion allocated to the Stargate initiative alongside billions in committed 2026 infrastructure budgets from Microsoft, Alphabet, Amazon, and Meta. Management monitors a non-binding qualified commercial pipeline estimated between $300 million and $500 million for tier-one AI infrastructure and GPU service deployments spanning North America and APAC. Executive oversight features CEO/Interim CFO Hoansoo Lee, with a board that includes Chairman Wenying Jia and Lead Director David Card (2021 Nobel Laureate in Economics). Prior capital formation is detailed through sequential SAFE tranches, capped by a March 2026 $3 million round at a $500 million valuation, followed by a January 2026 definitive merger agreement that sets a negotiated $500 million pre-money valuation without any attached third-party fairness opinion.
What changed: Draft Amendment No. 1 to Form S-4 Registration Statement combined with a Proxy Statement/Prospectus for the proposed business combination between D. Boral ARC Acquisition I Corp. (BCAR) and Exascale Labs Inc. This draft amendment explicitly discloses, according to BCAR management, that the $5,000,000 Minimum Cash Financing condition precedent remains unsecured as of April 22, 2026. The filing states that failure to secure this financing will block consummation, trigger the return of redeemed shares, and potentially force liquidation or an alternate target search. Why it matters: Per the filing, the unresolved financing condition introduces immediate execution risk that could derail the timeline before the February 1, 2027 (or May 1, 2027) deadline, directly impacting trust distribution mechanics and shareholder exit options.
What changed: Annual report on Form 10-K for fiscal year 2025. First annual report since IPO; reports trust value of $284.8M ($10.17/share), net income of $4.5M from interest, and post-year-end signing of merger agreement with Exascale Labs Inc. on January 11, 2026. Why it matters: Confirms trust value, deadline timeline (18 months from Aug 2025 with optional 3-month extension), and the execution of a $500M business combination agreement. Provides audited financials and details on sponsor arrangements and redemption mechanics.
What changed: a routine compliance exhibit (Schedule 13G/A beneficial ownership report). The filing updates prior disclosures for seven Sculptor Capital affiliated entities. It does not disclose adjusted share counts, voting power changes, or transaction-related mechanics. There are no alterations to the redemption timeline, trust accounting parameters, or merger approval status noted within the excerpt. Why it matters: Beneficial ownership amendments track institutional capital allocation and can precede governance shifts or liquidity decisions. This exhibit contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, or litigation. No executive commentary, sponsor conduct observations, or extension mechanisms are present. All disclosures are sourced exclusively to the listed Sculptor Capital entities. Because the filing attaches no share totals or stated purposes in the provided text, investors cannot derive near-term redemption behavior or deal progression signals from this page alone.
What changed: Schedule 13G/A beneficial ownership report amendment. Barclays PLC filed an amendment to its Schedule 13G to update its reported beneficial ownership position. The provided excerpt does not disclose the exact percentage of shares held or detail any numerical change in holdings. Why it matters: Regarding redemption deadlines, trust value, extensions, deal progress, or sponsor conduct, the filing contains no references to these mechanics. It does not address the $10.35 trust/share, the 2027-02-01 deadline, the DEAL_APPROVED status, or any modifications to sponsor commitments or redemption terms. As a routine institutional ownership update filed by Barclays PLC, the document bears no direct impact on the specified SPAC operational framework and contains no additional claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel.
What changed: In its own terms, this is a draft registration statement on Form S-4, confidentially submitted to the SEC on February 11, 2026, comprising a preliminary proxy statement and prospectus for a proposed business combination (de-SPAC merger) between D. Boral ARC Acquisition I Corp. (BCAR) and Exascale Labs Inc. The document confirms the January 11, 2026 Agreement and Plan of Merger mechanics remain intact without alteration: the automatic dissolution deadline is set for February 1, 2027, with a stated provision allowing the Sponsor to exercise a three-month extension to May 1, 2027. Why it matters: These disclosures directly frame the shareholder vote and redemption calculus. According to the BCAR Board’s stated rationale, the board approved the combination because it believes Exascale possesses 'strong revenue growth potential,' though the board acknowledged obtaining no independent fairness opinion. Warning letters highlight sponsor conflicts of interest, noting the Sponsor may earn positive returns even if public shareholders suffer negative ones, particularly if funds are released before February 1, 2027.
What changed: A Schedule 13G, which is a beneficial ownership report filed under Securities and Exchange Commission rules to publicly disclose equity holdings. According to the filing, Meteora Capital, LLC is identified as the reporting holder for BCAR. The excerpt provides no share quantities, percentage thresholds, transaction dates, or purchase prices, and it contains no language addressing redemption windows, trust account compositions, extension procedures, or the status of the approved business combination. Why it matters: The filing establishes public record of an institutional investor’s equity position, which creates baseline voting leverage that may influence shareholder approvals or redemption behavior. Because the excerpt omits the exact share count, acquisition dates, and investment purpose statement normally required in a 13G, the precise scale of Meteora Capital’s holding and its intent regarding the deal timeline or trust distributions cannot be assessed from this text.
What changed: A Schedule 13G/A beneficial ownership report — a routine compliance exhibit filed to update securities ownership disclosures. This excerpt contains no information bearing on redemption deadlines, trust value, extension triggers, deal progress, or sponsor conduct. No claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel are present, and therefore no statements to attribute to any party. Why it matters: As a bare filing header, this excerpt does not disclose amended share counts, voting intent, or transaction purposes that would influence capital commitment levels or pre-close liquidity dynamics. Monitoring the complete attachment set would be necessary to determine if Meteora Capital, LLC’s position affects shareholder sentiment or post-merger governance.
What changed: Schedule 13G joint filing agreement. This document is a Schedule 13G joint filing agreement. Reporting against redemption mechanics: it discloses zero changes to the trust value, redemption deadline, extension trajectory, target integration progress, or sponsor governance. The text contains only a joint filing declaration executed by Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Wong, authorizing Saul Ahn to submit a single beneficial ownership report on their collective behalf under Rule 13d-1(k). It references a principal statement dated January 21, 2026, but the exhibit itself omits share counts, acquisition costs, and holding purposes. Reporting remaining substance: the filing contains no claims regarding customers, revenue streams, addressable markets, corporate strategy, proprietary technology, commercial partnerships, ongoing litigation, or executive personnel movements. Why it matters: It formally links the reporting obligations of the listed Linden entities and Mr. Wong, indicating coordinated capital allocation ahead of the 2027 deadline. Because the exhibit is strictly the signing page and excludes the accompanying Schedule 13G schedules, investors cannot gauge block size, trading intent, or likely redemption volume. The substantive ownership data resides in the referenced January 21, 2026 filing.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.